Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5be9456a74cc707cc9ad4370982a402 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D9-0036 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B57-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-34 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B55-00 |
filingDate |
2016-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cbdcd08fc70922e442131aabb411f6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb8a71e544d7129c1f6603b0e699fe59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_258f61f1414588f6c3d09309d03d05e5 |
publicationDate |
2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
FR-3054218-A1 |
titleOfInvention |
PROCESS FOR DEDOLDING BACLOFENE SALTS |
abstract |
The present invention relates to the domain of the resolution of chiral compounds existing in the form of two optical antipodes (enantiomers), such as Baclofen. More particularly, the invention relates to the preparation of the pure enantiomer (R) (-) Baclofen, chemical nomenclature acid (R) -4-amino-3- (4-chlorophenyl) -butanoic acid and its hydrogenaleate salt . Most particularly, the present invention relates to the resolution of the hydrogenal maleate salts of racemic Baclofen by preferential crystallization and in particular by the AS3PC method (preferential polythermic crystallization programmed and self-seeded). |
priorityDate |
2016-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |